medline.ch Respirationstrakt Neoplasie

	[Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.]. Recenti Prog Med Belluomini L, Pilotto S. PMID: 41392795 [PubMed - indexed for MEDLINE]
	[Riscontro di anticorpi di tipo paraneoplastico anti-CRMP5 in corso di terapia con gli inibitori del checkpoint cellulare: un caso clinico.]. Recenti Prog Med Assandri R, Grassini A, Manzoni M, Padrenostro M, Ferrò MT. PMID: 41392790 [PubMed - indexed for MEDLINE]
	Reply to comment on "Plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer". Biomark Med Sheng Y, Yang L, Wang B, Hong Z, Guo J, Zhou C, Li T, Hu W, Gong Z. PMID: 41392754 [PubMed - as supplied by publisher]
	LiveWell: Pilot Feasibility Trial of an Adapted Dialectical Behavioral Therapy Skills Training Protocol in Patients With Metastatic Non-Small Cell Lung Cancer. Psychooncology Hyland KA, Neacsiu AD, Fisher HM, Cowperthwait CM, Chou N, Stinchcombe TE, Oeffinger KC, Porter LS, Dorfman CS, Keefe FJ, Somers TJ. PMID: 41392376 [PubMed - indexed for MEDLINE]
	Long-term oncological outcomes and recurrence patterns after segmentectomy for early-stage non-small cell lung cancer: A dual-center retrospective study. Eur J Cardiothorac Surg Brascia D, Mehta Warikoo I, Mangiameli G, Luppichini M, Marulli G, Colson YL. PMID: 41392202 [PubMed - as supplied by publisher]
	Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross-Sectional Study. Thorac Cancer Wei X, Liu J, Li H, Wang W, Zhao N, Dong C, Zhang S, Yu B, Wang M, Li M, Ning X, Zhang L, Si X. PMID: 41392025 [PubMed - indexed for MEDLINE]
	A Potential Path Toward Finally Improving Outcomes With Concurrent Immunotherapy and Chemoradiation for Lung Cancer: Low-Dose Radiation Therapy Lessons From the MATCH Trial in Extensive-Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys Simone CB 2nd. PMID: 41391922 [PubMed - in process]
	Unlocking Spondin-1 and Spondin-2 as Ultrasound-Responsive Biomarkers in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: Diagnostic and Therapeutic Perspectives. Cancer Biother Radiopharm Ou H, Jin F, Wang C, Wang S, Ye Y, Mo J, Wang F. PMID: 41391888 [PubMed - as supplied by publisher]
	Antibody-drug conjugates: a new twist to overcome EGFR-TKIs resistance in non-small cell lung cancer. Pharmacol Res Deng S, Sun C, Liu D, Zhang Y, Zhang J, Li X, Jia X, Kai G. PMID: 41391577 [PubMed - as supplied by publisher]
	Serum per- and polyfluoroalkyl substances in relation to circulating thyroxine levels and thyroid cancer risk: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial cohort. Environ Int Jung EM, Rhee J, Keil AP, Kitahara CM, Moore SC, Koponen J, Rantakokko P, Purdue MP. PMID: 41391234 [PubMed - as supplied by publisher]
	The benefit and risk of adding immunotherapy to chemoradiotherapy as the first-line treatment for limited-stage small cell lung cancer: a meta-analysis of randomized controlled trials. World J Surg Oncol Fu X, Zhang Y, Xu Y, Chen W, Hou Q, Zhang W, Zheng W. PMID: 41390407 [PubMed - as supplied by publisher]
	Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung). Eur J Cancer Cuppens K, Wiesweg M, Baas P, Maes B, Du Pont B, Ploenes T, Theegarten D, Vanbockrijck M, Aigner C, Hartemink K, Doerr F, Bölükbas S, Pat K, Schuler M. PMID: 41389771 [PubMed - as supplied by publisher]
	Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study. Cancer Treat Res Commun Preda AC, Krasteva R, Stjepanovi, Koynov K, Konsoulova A, Iorga GP, Udrea AA, Zgura A, Ciuleanu TE, Patru R, Arabadjiev J, Tonev I, Andri, Stojanovi, Pasca-Fenesan M, Pirvu EE, Iliev B, Kazmukov I, Petrov A, Nikoli, Mushmova M, Simic I, Georgescu OR, Schenker M. PMID: 41389683 [PubMed - as supplied by publisher]
	Are (18)F-FDG PET/CT based radiomics features useful for prediction of PD-L1 expression in non-small cell lung cancer? Hell J Nucl Med Yoon SH, Kim SJ. PMID: 41389262 [PubMed - as supplied by publisher]
	Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter, Prospective, Single-Arm, Phase 2 Trial. Cancer Med Fang W, Fang J, Tian P, Fan Y, Yu Q, Zhang X, Wang Z, Liu X, Shi Y, Zhang L. PMID: 41388935 [PubMed - indexed for MEDLINE]
	Hepatic steatosis detected on low-dose computed tomography in high-risk participants of a lung cancer screening program: a retrospective observational study. Intern Med J Bonney A, Chua M, Pascoe D, McCusker MW, Steinfort D, Sood S, Marshall H, Brims F, McWilliams A, Stone E, Fogarty P, Fong KM, Lam S, Manser R. PMID: 41388835 [PubMed - as supplied by publisher]
	Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score â‰¥50%: phase III study design. Future Oncol Reck M, Lu S, O'Byrne KJ, Barrios C, Pavlov D, Tay F, Negrao MV. PMID: 41388832 [PubMed - as supplied by publisher]
	Associations of diabetes status, duration, and onset age with the risk of lung cancer: Results from the China Kadoorie Biobank study. Int J Cancer Su J, Hua J, Fan X, Wan X, Lu Y, Jin J, Hua Y, Pei P, Sun D, Yu C, Lv J, Wu M, Zhou J, Tao R. PMID: 41388620 [PubMed - as supplied by publisher]
	Microflora: a promising potential in the diagnosis and treatment of non-small cell lung cancer. Int J Clin Oncol Wang L, Chi Y, Zhang M, Jiang J, Meng Z, Wang Z. PMID: 41388199 [PubMed - as supplied by publisher]
	Prognostic Implications of SMARCA4, ARID1A, and Other BAF Mutations in Non-Small Cell Lung Cancer. Cancer Med Khalil A, Collins MP, Quintás-Cardama A. PMID: 41387924 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 155730

Seite 1 von 7787



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung